We are live on
!
Find out more
NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.39B
1-Year Est. Return
97.11%
This Fund
S&P 500
This Quarter
Est. Return
+11.76%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.08B
AUM Growth
+$20.7M
(+2%)
Cap. Flow
-$60.6M
Cap. Flow
% of AUM
-5.62%
Top 10 Holdings %
Top 10 Hldgs %
20.95%
Holding
208
New
36
Increased
50
Reduced
44
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cytokinetics
CYTK
|
+$22.8M |
| 2 |
Legend Biotech
LEGN
|
+$18.8M |
| 3 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$16.1M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$16M |
| 5 |
United Therapeutics
UTHR
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$20M |
| 2 |
HealthEquity
HQY
|
+$18.6M |
| 3 |
Element Solutions
ESI
|
+$17.4M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$14.2M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.2% |
| 2 | Technology | 15.96% |
| 3 | Industrials | 9.72% |
| 4 | Energy | 6.59% |
| 5 | Consumer Staples | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Tenable Holdings
TENB
$4.01B
| – | – |
-51,971
| Closed | -$2.36M |
|
177
Alpha Teknova
TKNO
$347M
| – | – |
-715,449
| Closed | -$6.01M |
|
178
Twilio
TWLO
$36.6B
| – | – |
-8,351
| Closed | -$700K |
|
179
Varonis Systems
VRNS
$5B
| – | – |
-70,562
| Closed | -$2.07M |
|
180
VistaGen Therapeutics
VTGN
$12.8M
| – | – |
-148,528
| Closed | -$3.92M |
|
|
NAPA
181
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| – | – |
-164,516
| Closed | -$3.46M |
|
|
SLGC
182
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – |
-1,576,754
| Closed | -$7.13M |
|
|
SGEN
183
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-61,202
| Closed | -$10.8M |
|
|
NEX
184
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| – | – |
-281,447
| Closed | -$2.68M |
|
|
ALBO
185
DELISTED
Albireo Pharma Inc
ALBO
| – | – |
-430,878
| Closed | -$8.56M |
|
|
BHVN
186
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-137,306
| Closed | -$20M |
|
Similar funds
FFM
1CP
OCM
OCAM
TA
AU
RIM
BCP
Nicholas Investment Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Nicholas Investment Partners held 208 positions worth $1.08B, up 2% from $1.06B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Nicholas Investment Partners withdrew a net $60.6M in Q3 2022, closing 33 positions and reducing 44 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $20M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.
Against the trend, Nicholas Investment Partners opened a new position in Cytokinetics worth $22.9M.
- Nicholas Investment Partners's largest Q3 2022 buy was Cytokinetics: 472,839 shares worth $22.9M.
- Nicholas Investment Partners added most to Callaway Golf Company in Q3 2022, an estimated $9.5M increase.
- Nicholas Investment Partners's biggest Q3 2022 reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $14.2M.
- Nicholas Investment Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $20M.
- Nicholas Investment Partners's ten largest holdings make up 21% of its $1.08B portfolio in Q3 2022.
- Nicholas Investment Partners opened 36 new positions and closed 33 in Q3 2022.
- Nicholas Investment Partners's portfolio value rose 2% quarter-over-quarter to $1.08B.
Based on Nicholas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.